HB 768 (see companion bill SB 759) – MarylandStatus: Enacted
Year Introduced: 2019
Year Enacted: 2019
Establishing the Prescription Drug Affordability Board as an instrumentality of the State the purpose of which is to protect State residents and certain stakeholders within the health care system from the high costs of prescription drug products; requiring certain conflicts of interest to be considered when appointing Board members; requiring the Board to identify certain prescription drug products with certain costs; establishing the Prescription Drug Affordability Stakeholder Council; etc.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.